RU94036715A - Medicinal agent for children treatment with asiderotic anemia - Google Patents

Medicinal agent for children treatment with asiderotic anemia

Info

Publication number
RU94036715A
RU94036715A RU94036715/14A RU94036715A RU94036715A RU 94036715 A RU94036715 A RU 94036715A RU 94036715/14 A RU94036715/14 A RU 94036715/14A RU 94036715 A RU94036715 A RU 94036715A RU 94036715 A RU94036715 A RU 94036715A
Authority
RU
Russia
Prior art keywords
medicinal agent
ferbitol
sugar syrup
children
treatment
Prior art date
Application number
RU94036715/14A
Other languages
Russian (ru)
Other versions
RU2098102C1 (en
Inventor
Н.Д. Сидорова
Е.А. Селиванов
Н.П. Сивакова
Н.Н. Пятовская
Л.В. Слепнева
Л.А. Седова
Original Assignee
Российский научно-исследовательский институт гематологии и трансфузиологии
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Российский научно-исследовательский институт гематологии и трансфузиологии filed Critical Российский научно-исследовательский институт гематологии и трансфузиологии
Priority to RU94036715A priority Critical patent/RU2098102C1/en
Publication of RU94036715A publication Critical patent/RU94036715A/en
Application granted granted Critical
Publication of RU2098102C1 publication Critical patent/RU2098102C1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

FIELD: medicine, pediatry. SUBSTANCE: proposed agent has ferbitol, sodium fumarate, sugar syrup at the following ratio, %: ferbitol 40-60; sodium fumarate 8-10; sugar syrup 20-30, and water for injection - up to 1 l. EFFECT: enhanced effectiveness of agent.

Claims (1)

Изобретение относится к медицине, а именно к педиатрии и может быть использовано для лечения желеэодефицитной анемии у детей. Предлагаемое лекарственное средство содержит фербитол, натрия фумарат, сироп сахарный в следующих соотношениях,%: фербитол 40-60, натрия фумарат 8-10, сироп сахарный 20-30, вода для инъекций - до 1 л.
Figure 00000001
The invention relates to medicine, namely to pediatrics and can be used for the treatment of jelly-deficiency anemia in children. The proposed drug contains ferbitol, sodium fumarate, sugar syrup in the following proportions,%: ferbitol 40-60, sodium fumarate 8-10, sugar syrup 20-30, water for injection - up to 1 liter.
Figure 00000001
RU94036715A 1994-09-26 1994-09-26 Medicinal agent for asiderotic anemia treatment in children RU2098102C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94036715A RU2098102C1 (en) 1994-09-26 1994-09-26 Medicinal agent for asiderotic anemia treatment in children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94036715A RU2098102C1 (en) 1994-09-26 1994-09-26 Medicinal agent for asiderotic anemia treatment in children

Publications (2)

Publication Number Publication Date
RU94036715A true RU94036715A (en) 1996-07-10
RU2098102C1 RU2098102C1 (en) 1997-12-10

Family

ID=20161140

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94036715A RU2098102C1 (en) 1994-09-26 1994-09-26 Medicinal agent for asiderotic anemia treatment in children

Country Status (1)

Country Link
RU (1) RU2098102C1 (en)

Also Published As

Publication number Publication date
RU2098102C1 (en) 1997-12-10

Similar Documents

Publication Publication Date Title
RU95101387A (en) Argatroban concentrated aqueous solution
YU47899B (en) PROCEDURE FOR OBTAINING PREPARATIONS PREVENTING THE TRANSMISSION OF SEXUAL DISEASES AND THE TAMPONS CONTAINING IT
DE69519300T2 (en) STABLE MEDICINAL PRODUCT CONTAINING OXALIPLATINE
YU54499A (en) Pharmaceutical compositions for application to mucosa
HK1028957A1 (en) Use of n,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of chronic pain
TR199701294T1 (en) Composition consisting of amoxicillin and clavulanic acid.
RU95101385A (en) Products containing g-csf and tnf-binding protein
RU94021635A (en) A PREPARATION FOR THE TREATMENT OF SURFACE CHANGES OF THE SKIN AND MUCOSIS AND A METHOD FOR ITS OBTAINING
RU94036715A (en) Medicinal agent for children treatment with asiderotic anemia
ATE401394T1 (en) IMPROVED DNASE LIQUID SOLUTIONS
ATE233085T1 (en) MEDICINAL PRODUCTS FOR TOPICAL USE
KR910004186A (en) Pharmaceutical Formulations
RU94036618A (en) Medicinal agent for asiderotic anemia treatment
RU94042579A (en) Agent for stopping alcohol abstinent syndrome
RU94039553A (en) Agent for chronic prostatitis treatment
RU94004904A (en) Agent for treatment of leukosis and method of leukosis treatment
RU2001122151A (en) DRUG FOR TREATMENT OF ACUTE POST-NENAL ENDOMETRITIS IN COWS AND METHOD OF ITS APPLICATION
RU94020847A (en) Tranquilizing agent
RU94029806A (en) Method of prophylaxis and treatment of viral and bacteriological diseases
RU94003002A (en) Method of prolongation of thymolol therapeutic action
RU94039211A (en) Antibacterial agent
RU95105084A (en) Natural hepatoprotective agent
RU96110626A (en) SWEET DRINK "KRYUKVA ON KNJAK"
RU93031248A (en) METHOD OF TREATMENT OF CHRONIC GLOMERULEEPHRITIS
RU93058235A (en) STIMULATING AND TONING AGENT